Table 1 Clinical features of all participants in the chronic sugar-sweetened beverage intake urate analysis
Percentage with data | All (n = 12,870) | BMI <25 (n = 5,002) | BMI ≥25 (n = 7,862) | P | |
|---|---|---|---|---|---|
Age, years | 100 | 49.5 (10.1) | 48.9 (10.4) | 49.9 (9.9) | 9 × 10−9* |
Male sex, n (%) | 100 | 6030 (46.9) | 1740 (34.8) | 4288 (54.5) | <1.0 × 10−5** |
NZ East Polynesian dataset, n (%) | 100 | 583 (4.5) | 96 (1.9) | 487 (6.2) | <1.0 × 10−5** |
NZ West Polynesian dataset, n (%) | 100 | 271 (2.1) | 16 (0.3) | 255 (3.2) | |
NZ Mixed East/West Polynesian dataset, n (%) | 100 | 64 (0.5) | 4 (0.1) | 60 (0.8) | |
NZ Caucasian dataset, n (%) | 100 | 450 (3.5) | 152 (3.0) | 298 (3.8) | |
ARIC Caucasian dataset, n (%) | 100 | 6927 (53.8) | 2930 (58.6) | 3996 (50.8) | |
FHS Caucasian dataset, n (%) | 100 | 3066 (23.8) | 1380 (27.6) | 1686 (21.4) | |
ARIC African American dataset, n (%) | 100 | 1509 (11.7) | 424 (8.5) | 1080 (13.7) | |
Serum urate, mmol/L | 98.4 | 0.33 (0.09) | 0.30 (0.07) | 0.36 (0.08) | <1.0 × 10−300* |
Triglycerides, mmol/L | 98.0 | 1.79 (1.52) | 1.45 (1.04) | 2.01 (1.72) | <1.0 × 10−300* |
Body mass index, kg/m2 | 99.9 | 27.1 (5.4) | 22.4 (1.8) | 30.1 (4.8) | <1.0 × 10−300* |
Fruit intake, pieces/day | 99.8 | 1.47 (1.31) | 1.45 (1.32) | 1.48 (1.31) | 0.32* |
Kidney disease, n (%) | 96.3 | 134 (1.1) | 34 (0.7) | 100 (1.3) | 1.4 × 10−3** |
Hypertension, n (%) | 99.3 | 1541 (12.1) | 395 (7.9) | 1143 (14.7) | <1.0 × 10−5** |